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Abstract 
According to the Global Information System on Alcohol and Health (GISAH), 
alcohol consumption causes more than 2.5 million deaths annually. This organization 
also attributes more than sixty different diseases in which alcoholism plays a significant 
role. Such diseases include the Human Immunodeficiency Virus (HIV) and Acquired 
Immune Deficiency Syndrome (AIDS) (WHO, 2014). There are over 50,000 new cases 
of HIV reported each year.  In the United States, it is estimated that more than 1.1 million 
people are infected with HIV, and about one in six people are completely unaware that 
they are infected (CDC.gov, 2013). A systematic literature review was done on twenty 
different studies to see the effects that the consumption of alcohol may have on adherence 
to highly active antiretroviral therapy (HAART) and the progression of HIV. This 
literature review examined these effects by looking at CD4+ cell levels, viral load, 
disease progression, and early mortality rates. In the results, it was shown that there may 
be a possible correlation between the consumption of alcohol and HAART non-
adherence, as well as the consumption of alcohol causing disease progression and early 
death. This review also found that several different studies considered HAART non-
adherence to be a multifactorial issue, which should be further researched to help with the 
treatment of HIV. In conclusion, an assessment of the consumption of alcohol should be 
done in all patients diagnosed with HIV/AIDS. Patient teaching is needed to teach about 
the possible effects that alcohol may have on HAART, and referral to support groups is 
needed to help with adherence to HAART therapy. Prevention strategies should be 
formed to help decrease the spread of HIV/AIDS in the United States. 
Key Terms: HIV/AIDS, Alcohol consumption, highly active antiretroviral 
therapy, disease progression, adherence, and non-adherence 
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Chapter One: Introduction  
 The consumption of alcohol during antiretroviral therapy may lead to medication 
non-adherence. Non-adherence could lead to both the progression and spread of 
HIV/AIDS. (Samet et al., 2004). When moderate amounts of alcohol are consumed, it can 
block the absorption of antiretroviral medications in the stomach. When the absorption is 
blocked, the patient receives an inadequate amount of the medication thereby reducing 
effectiveness of the antiretroviral medication.  The consumption of alcohol can also block 
the metabolism of the antiretroviral medication in the liver. When the metabolism of the 
anti-retroviral is blocked in the liver, the medication stays in the system longer causing 
toxicity or increasing side effects. When a patient exhibit sides effects of medication they 
are more likely to skip doses, or discontinue the medication which can lead to non-
adherence (Wilson, 1995). Since alcohol is an immunosuppressant, the consumption of 
alcohol among patients infected with HIV/AIDS taking HAART may increase their 
susceptibility to opportunistic infections (Baum et al., 2010).  Lastly, when consuming 
large amounts of alcohol, the growth rate of HIV increases causing a viral overload and a 
decrease in CD4+ cells (Wilson, 1995).  
Since the creation of HAART therapy in 1996, there have been developments in 
both the immune and viral outcomes in the treatment of HIV. In addition, both the life 
span and the quality of life have been increased in patients who are infected with 
HIV/AIDS. However, in order for the benefits of HAART to be achieved, patients must 
adhere to the medication regimen. The consumption of alcohol has been related with 
HAART non-adherence in multiple studies, yet the characteristics of the correlation are 
still vague and further research is still needed (Hendershot et al., 2009).   
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It was in the 1980's when the consumption of alcohol increased, and today a little 
over five liters per adult person is consumed every year worldwide. According to Baum 
et al. (2010), alcohol abuse was the third leading cause of death in 2007, with 
approximately five percent of the population drinking heavily and fifteen percent of the 
population binge drinking. The consumption of alcohol is common in populations 
infected with HIV/AIDS. Some studies show a prevalence of alcohol abuse of up to fifty 
percent in patients infected with HIV/AIDS (Baum et al., 2010).   
During the release of HAART therapy, the research of the relationship between 
the consumption of alcohol and the disease progression of HIV was not adequately 
researched. The focus was placed on treating patients with this newly developed 
medication rather than looking at the possible effects of alcohol on patients infected with 
HIV/AIDS. The effects of alcohol and HARRT therapy was not considered at this time 
(Samet et al., 2003). There are several studies on the consumption of alcohol and HIV 
disease progression that came about after the introduction of HAART. According to 
Baum et al. (2010), these studies established that alcohol results in an increase in the viral 
load, a decrease in CD4+ cells, and a decrease in adherence to HAART (Baum et al., 
2010). This systematic literature review will look at research dealing with alcohol 
consumption and its relationship to the progression of HIV and adherence to HAART 
therapy. 
Problem Statement: 
 Patients who are infected with HIV or AIDS must adhere to their medications 
regime in order to prevent the progression of HIV. They must also keep viral load levels 
low which decrease the effects of the virus on the body thereby decreasing complications 
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of the disease (AIDS.gov, 2012). Alcohol is a potential issue with antiretroviral 
medications because it is thought to affect patients negatively (Kalichman, 2009).  
According to Manuela et al. (2012), there is research that reports that alcohol 
consumption leads to the resistance of HAART, co-morbidity, and an increase in 
mortality rates. Given the spread of HIV/AIDS in the United States, the research shows 
that alcohol may negatively affect HAART compliance thereby causing non-adherence 
and subsequence progression of the disease. 
Purpose of the Study: 
  The purpose of this study was to perform a systematic literature review of 
numerous research articles that examine the effects of alcohol on HIV/AIDS patients 
taking HAART. This review also explored research related to alcohol consumption as a 
catalyst leading to the progression of HIV/AIDS in patients who consume alcohol while 
prescribed anti-retroviral therapy.  A descriptive correlational design was used.  
 This study could become the catalyst for future research to understand how to prevent 
the rise and spread of HIV/AIDS in patients who drink alcohol while taking HAART. 
Hopefully, the management of HIV and AIDS patients receiving HAART therapy will be 
improved.   
Research Questions: 
 Research Question 1: Is there a correlation between alcohol consumption and 
HAART non-adherence? 
Hypothesis 1 
H1: There is a positive correlation between alcohol consumption and HAART adherence 
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H0: There is not a positive correlation between alcohol consumption and HAART 
adherence 
 Research Question 2: Doses alcohol consumption play a role in the disease 
progression of HIV?  
Hypothesis 1 
H1: Alcohol consumption does play a role in the disease progression of HIV?  
H0: Alcohol consumption does not play a role in the disease progression of HIV? 
Definition of Terms: 
 Human Immunodeficiency Virus is a virus that can only be acquired by humans. 
This virus attacks and destroys the CD4+ cells in the body, which leads to a weakened 
immune system. Patients with HIV will have a CD4+ cell count less than 500 cells/mm3 
(AIDS.gov, 2012). 
 Acquired Immunodeficiency Syndrome is an acquired syndrome because it is 
acquired after birth. Also, it is named a syndrome because it is a complex disease that has 
a range of different complications and symptoms. Patients with AIDS will have a CD4+ 
cell count less than 200 cells/mm3 (AIDS.gov, 2012). 
 A viral load is the quantity of HIV in the patient's blood. Antiretroviral 
medications are used to treat symptoms of HIV/AIDS by lowering the viral load in the 
body (AIDS.gov, 2012). The viral load and the CD4+ cells count are directly correlated 
when the viral load is high the CD4+ cell count is low and vice versa. (U.S. Department 
of Veteran Affairs, 2013).  
  CD4+ cells are the cells that send signals to activate the body's immune response 
when foreign bodies such as viruses or bacteria have entered the body. The CD4+ cells 
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are otherwise known as T-cells, and these are the cells that fight off infections and 
diseases in the body (AIDS.gov, 2012). 
 Opportunistic infections are infections that take advantage of weakened immune 
systems that cause severe illnesses (U.S. Department of Veteran Affairs, 2013). If 
patients have more than one opportunistic infection, they will be diagnosed with AIDS 
regardless of their CD4+ cell count (CDC.gov, 2013). Opportunistic infections are 
infections such as Tuberculosis, Candidiasis, and Histoplasmosis (AIDS.gov, 2012). 
 For the purpose of this study, adherence will refer to HIV/AIDS patients, who are 
prescribed antiretroviral medication and are taking the medication as prescribed. Non-
adherence will refer to HIV/AIDS patients who are prescribed antiretroviral medication 
and purposely skip or forget to take prescribed medications as prescribed. Non-adherence 
can lead to the resistance of prescribed medications.  If a patient becomes resistant to 
prescribed medication, the medication no longer works for a patient infected with 
HIV/AIDS. Resistance happens when the body creates a mutated strain of the virus that 
does not respond to the medication. When the patient becomes resistant to medications, 
the virus is no longer impeded from multiplying which results in a higher viral load and 
progression of the disease (U.S. Department of Veteran Affairs, 2013). 
Many studies that examine alcohol consumption in patients infected with 
HIV/AIDS use the categories of: (a) non-drinkers or abstainers, (b) hazardous drinkers or 
binge drinkers, and (c) non-hazardous drinkers or non-binge drinkers. Non-drinkers or 
abstainers are those who do not consume any alcohol. Hazardous drinkers or binge 
drinkers are those who consume more than five drinks on the day that they consume 
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alcohol. Non-hazardous drinkers or non-binge drinkers are those that consume less than 
five drinks on the day they consume alcohol (Braithwaite et al., 2007). 
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Chapter Two: Literature Review 
Alcohol Consumption and HAART: 
After HAART became the treatment of choice for HIV/AIDS, studies began to 
examine the effects of certain factors that affect HAART such as the consumption of 
alcohol. According to Baum et al. (2010), such studies established that alcohol results in 
an increase in the viral load, a decrease in CD4+ cell levels, and a decrease in adherence 
to HAART (Baum et al., 2010). This systematic literature review examined the results of 
these studies.  
According to Miguez et al. (2003), a cross-sectional analysis of HIV-infected 
drug users found that patients who consumed alcohol four or more times per week and 
who were receiving HAART, were four times less likely to achieve a reduced viral load 
and two times more likely to have CD4+ cell count below 500 cell/mm³ than moderate 
drinkers or abstainers (as cited in Baum et al., 2010).   
According to Fabris et al. (2000), a small prospective study of patients infected 
with HIV taking HAART, found that there was no difference in those who attained a 
reduced viral load or decreased CD4+ cell count between heavy alcohol drinkers, 
moderate alcohol drinkers, and abstainers (as cited in Baum et al., 2010). However, a 
larger longitudinal study of patients infected with HIV with a history of alcohol problems 
found that the consumption of alcohol was significantly correlated with a decreased 
adherence to HAART and was negatively related with HIV viral load suppression (Samet 
et al., 2004). Also, according to Howard et al. (2002), a prospective study of 161 patients 
infected with HIV on ART found that poor adherence to HAART was considerably 
related to the consumption of alcohol (as cited in Baum et al., 2010). 
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According to Baum et al. (2010), the findings suggest that the consumption of 
alcohol may accelerate the progression of HIV through poor adherence to HAART. 
However, a seven-year prospective study on the relationship between heavy alcohol 
consumption and lower CD4+ cell counts in a cohort with HIV-positive patients not on 
HAART indicates that the consumption of alcohol may directly influence the progression 
of HIV through an effect on the CD4+ cell count (Samet et al., 2007).  All patients with 
HIV or AIDS are treated with antiretroviral therapy. Anti-retroviral therapy is used to 
suppress the replication of the virus thereby improving the immune system. It is also used 
to increase the number of CD4+ cells which helps protect patients from opportunistic 
infections (Manuela et al., 2012).The goal of the treatment is to have positive outcomes, 
which will require close adherence to the medication regimen. If non-adherence occurs, 
then the virus can replicate and develop resistance, which can affect the patient 
negatively (Kalichman et al., 2009). 
HIV/AIDS 
 There is no cure for HIV/AIDS. Taking medications for the treatment of 
HIV/AIDS is important because it can control symptoms and slow down the progression 
of the disease (AIDS.gov, 2012). However, the medications can only work if they are 
taken and taken correctly. The history of non-adherence to HIV/AIDS medications is a 
major problem. There are many reasons for medication non-adherence. However, but 
according to the research, alcohol consumption could be a major causative factor in 
medication non-adherence in patients with HIV/AIDS. According to Cook et al. (2001), it 
was found that nineteen percent of HIV-infected patients reported a drinking problem. 
Also, according to Cook et al. (2001), it was shown the compared with non-problem 
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drinkers, problem drinkers were more likely to take HAART off schedule (Cook et al., 
2001).  
 In the United States, it is estimated that more than 1.1 million people are infected 
with HIV, and about one in six people are completely unaware that they are infected 
(CDC.gov, 2013). Human Immunodeficiency Virus has been traced back to a type of 
chimpanzee in West Africa (AIDS.gov, 2012). Scientists have identified these 
chimpanzees to be the source of infection found in humans (CDC.gov, 2014). Scientists 
believe that the simian immunodeficiency virus (SIV), the chimpanzee type of 
immunodeficiency virus was transmitted to humans where it transformed into HIV. It is 
believed that humans probably came in contact with the virus as far back as the 1800's by 
coming in contact with the infected blood from the chimpanzees when they hunted and 
ate them (AIDS.gov, 2012). Human immunodeficiency virus then spread slowly from 
Africa to other parts of the world. The virus has been in the United States since the mid to 
late 1970's (CDC.gov, 2014).    
  Human immunodeficiency virus can be found in many specific human body 
fluids, so patients become infected once HIV-infected fluids enter the body (CDC.gov, 
2014). Fluids that contain high levels of HIV are blood, semen, pre-seminal fluid, breast 
milk, vaginal fluids, and rectal mucous. These fluids can be transmitted by sexual 
contact, pregnancy, childbirth, breastfeeding, intravenous drug use, occupational 
exposure, a blood transfusion, and even through an organ transplant (AIDS.gov, 2012). 
These fluids must come in contact with a mucous membrane, damaged tissue, or be 
directly injected into the blood stream by needle or syringe for the transmission of HIV to 
occur (CDC.gov, 2014). 
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   Human immunodeficiency virus in the United States is mainly spread by having 
sex that is unprotected (CDC.gov, 2014). During sexual contact, whether it be oral, anal 
or vaginal, a person can come into contact with HIV infected body fluids. The body 
fluids can transmit the virus through the bloodstream through tiny cuts in the delicate 
linings of the vaginal canal, vulva, penis, rectum, and even the mouth (AIDS.gov, 2012).  
Anal sex has the highest risk of transmission while vaginal sex is the second-highest risk 
of transmission (CDC.gov, 2014). Patients can be diagnosed as HIV positive by taking 
two tests, a preliminary enzyme immunoassay (EIA) test and a confirmatory Western blot 
test. If these tests are positive, it means the patient is HIV-positive. This means that it is 
possible for them to pass the virus to others (AIDS.gov, 2012). Just because a patient 
receives a negative test result, does not mean they are not HIV positive. A negative test 
result can appear depending on when the patient may have been exposed to HIV 
(CDC.gov, 2014). 
 Once patients are diagnosed with HIV, it means that their CD4+ cell count is less 
than 500 cells/mm³. A normal CD4+ cell count is 800-2500 cells/mm³. When the CD4+ 
cell count reaches 350 cells/mm³ or below treatment needs to be started because the 
person is at risk for opportunistic infections. When a patient becomes infected with AIDS 
or the third stage of HIV, their CD4+ cell count will be below 200 cells/mm³. To slow the 
progression of HIV/AIDS and to treat the symptoms of HIV/AIDS, patients must take 
HAART (AIDS.gov, 2012).   
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Chapter Three: Methodology 
Purpose and Research Design: 
  The purpose of this study was to perform a systematic literature review to 
examine the effects of the consumption of alcohol on patients infected with HIV/AIDS 
taking HAART. A systematic literature review was performed to find a more conclusive 
answer of how alcohol consumption affects patients infected with HIV/AIDS and 
prescribed HAART. The literature review encompassed research published in the United 
States during the years 2001-2012. It observed both men and women age eighteen and 
older, who were infected with HIV or AIDS, and who consume alcohol while taking 
HAART.  
Data Collection 
 In the systematic literature review, a database search using Academic Search 
Premier, PubMed, Medline, Scopus, and Cinahl was done. Key terms used included; 
HIV/AIDS, Alcohol consumption, highly active antiretroviral therapy, disease 
progression, adherence, and non-adherence.  The search was then narrowed by making 
sure it was peer-reviewed articles and by using the specific term "United States", so that 
no articles outside of the United States were pulled up. The research articles were then 
reviewed to see if they fulfilled the requirements or criteria.  
Criteria 
The criteria that were used for this research process was that all studies reviewed 
must consist of patients age eighteen years or older. Subjects could be female or male. 
The subjects included needed to have consumed alcohol while taking HAART. All 
studies must have been done within the United States. Also, each study needed to include 
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topics that look at the relationship between HIV/AIDS, alcohol consumption, and highly 
active anti-retroviral therapy.  
By using the criteria as a guide, this researcher then searched extensively for 
studies that met all the criteria and requirements. This assisted with the decision of 
inclusion or exclusion of the different studies for the systematic literature review. The 
quality of each study was then determined by the strength of each article. A summary of 
each study was then done in order to explore the differences between each of the studies, 
to identify patterns among each of the study results, any contrast of results, or other 
relationships that may arise within the studies.   
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Chapter Four: Results 
Effects of Alcohol on Adherence 
In the following studies, it is seen that the consumption of alcohol may have an 
effect on adherence to HAART therapy in patients with HIV. The results of the 
Systematic Literature Review are summarized in Table 1. 
In the first study chosen, the relationship between the consumption of alcohol and 
adherence to HAART therapy was researched through an observational study at eight 
different sites for HIV-positive veterans in a Veterans Aging Cohort Study. In this study, 
telephone surveys were performed to see if non-adherence to HAART therapy was 
associated with alcohol consumption. A total of 2,702 HIV-positive veterans were 
chosen. Of those the veterans chosen, 1,582 did not drink alcohol, 931 veterans were non-
binge drinkers or non-hazardous drinkers, and 239 veterans were hazardous drinkers or 
binge drinkers. The veterans who abstained from alcohol missed medications only a little 
over two percent on the days surveyed. Non-hazardous drinkers or non-binge drinkers 
missed medications three and a half percent on days surveyed, and binge or hazardous 
drinkers missed medications eleven percent on surveyed days. Overall, the results of this 
study show that there may be an association between the consumption of alcohol and 
non-adherence in HAART therapy (Braithwaite et al., 2005).  
In a cross-sectional analysis of 1,529 HIV-positive veterans, the association of 
alcohol and non-adherence to HAART therapy is researched by looking as far back as 
thirty days for drinking histories. This was done to find out adherence practices when 
drinking alcohol by performing telephone interviews. Within this study, it was realized 
through the telephone interviews that significant non-adherence was correlated with 
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consuming alcohol because patients who had at least two alcoholic drinks were non-
adherence to their antiretroviral therapy. Anything over two alcoholic drinks showed 
significant non-adherence with patients taking HAART (Braithwaite et al., 2008).  
In an observational clinical cohort of 1,711 HIV-positive patients, adherence 
practices to HAART when consuming alcohol was researched. In this study, patients 
partook in 5,028 interviews with ten percent of the patients being hazardous or binge 
drinkers and forty-five percent of the patients consuming alcohol in general. Hazardous 
or binge drinkers had a thirty-five percent decrease in adherence to HAART therapy 
compared to those patients who did not drink any alcohol. It can be seen in the results of 
this study that a high correlation exists between the consumption of alcohol and HAART 
non-adherence (Chander et al., 2006) 
Another study searching for a correlation between alcohol and non-adherence to 
HAART therapy was done in a cross-sectional survey. In this cross-sectional survey, 
seventy-five HIV positive patients were given questionnaires at ten different sites. Over 
eleven percent of patients stated they missed at least one dose of HAART the day before, 
and over seventeen percent said they missed at least one dose of HAART two days before 
the interview. Patients in this study had multiple reasons for missing doses with sixty-six 
percent forgetting to take the dose altogether, and fifty-three percent being too busy to 
take HAART. Overall, all patients were more likely to consume alcohol or were taking 
drugs at the time of the study. In this particular study, multiple factors were suggested as 
being the reason for non-adherence to HAART therapy (Chesney et al., 2000). 
In the next study, a Cross-sectional survey with 212 HIV-positive patients was 
done at two different outpatient clinics. At these two different sites, patients reported 
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their adherence to HAART through surveys. Results from the surveys showed nineteen 
percent had reported hazardous or binge drinking during the last month. Fourteen percent 
had reported missing a dose or more within the last day, and thirty percent of the patients 
did not adhere to the time medications were scheduled during the last week. Among all 
patients who drank, hazardous drinkers or binge drinkers were more likely to miss a dose 
and take HAART off schedule with seventeen percent being binge drinkers and fifteen 
percent being hazardous drinkers. According to Cook et al. (2001), non-adherence to 
HAART therapy was associated with hazardous drinking or binge drinking because 
hazardous drinkers or binge drinkers were most likely to report non-adherence to 
HAART (Cook et al., 2001). 
 In a prospective cohort study with a total of 140 HIV-positive patients on 
HAART, medication adherence was checked every four weeks at a county HIV clinic. 
This was achieved by doing pill counts and through patients self-report to the clinic. The 
patients who reported drinking alcohol were adherent to sixty-six percent of the doses 
compared to being adherent seventy-four percent of the time like non-drinkers. Also, it 
was shown that patients who used pill boxes or timers as an aid to take doses took 
seventy-eight percent of the doses compared to taking sixty-six percent of doses with no 
help from timers or pill boxes (Golin et al., 2002). 
In another study, a meta-analysis was done with over 25,000 HIV positive 
patients in over forty different studies. A literature review was performed to find a 
correlation between the consumption of alcohol and non-adherence to HAART. In the 
results, those who consumed alcohol were only between fifty to sixty percent adherent to 
HAART therapy compared to patients who abstained from drinking and were ninety-five 
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percent adherent to HAART therapy. In this study, non-adherence to HAART was 
strongly correlated with the consumption of alcohol in patients with HIV (Hendershot et 
al., 2009).  
In a cross-sectional study of 659 HIV-positive patients, patients were randomly 
selected from fourteen different sites. Patients were asked questions about alcohol use in 
the past month, and CD4+ cell levels and viral load levels were pulled from the clinical 
database. Over forty-two percent of the patients reported alcohol use in the last four 
months while on HAART. Patients who were hazardous drinkers or binge drinkers 
presently were more likely to be non-adherent than former binge drinkers or hazardous 
drinkers and patients who abstained from consuming alcohol altogether. Being a former 
drinker did not affect adherence at all, and current drinkers were more non-adherent to 
HAART (Hicks et al., 2007). 
In a longitudinal random control trial, 224 HIV-positive patients were used to see 
if the consumption of alcohol was associated with non-adherence to HAART. In this 
study, adherence to HAART was checked at two weeks, three months, six months, and 
nine months at an outpatient HIV clinic through a medication adherence questionnaire. 
Also, alcohol consumption was checked through an alcohol use disorder identification 
test. The findings of this study showed that alcohol negatively impacted adherence to 
HAART therapy at each checkpoint except at three months.  It was shown that social 
support helped with adherence. Overall, social support with taking medications could 
help with the negative impacts of alcohol use on adherence to HAART therapy (Lehavot 
et al., 2011).  
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In another study, a prospective cohort of 695 HIV-positive patients in an urban 
clinic was performed. Patients in this study completed surveys that addressed both 
adherence to HAART and consumption of alcohol. Patients who went from not drinking 
to consuming hazardous amounts of alcohol were seen to be less adherent than those 
patients who were hazardous drinkers and stopped drinking during HAART therapy. 
Also, patients who went from not drinking to consuming hazardous amounts of alcohol 
had an increase in CD4+ cell levels (Lucas et al., 2002).  
In another study, cross-sectional data was pulled from a prospective observational 
cohort using fifty-two women with children to investigate their adherence to HAART 
therapy. Adherence was checked using a questionnaire given to the mothers to see what 
may be causing their non-adherence to HAART. Within their questionnaires, researchers 
found adherence rates to be from forty-three percent to fifty-six percent. It was found that 
many different factors lead to the poor adherence rates. These factors included alcohol 
consumption, stress from motherhood, and things such as having a partner or having 
inadequate beliefs about the benefits of HAART therapy. This study shows that alcohol 
could be a part of multiple factors that lead to non-adherence making it a multi-factorial 
problem that should be further researched (Murphy et al., 2002).  
In a prospective cohort, 349 patients who were HIV positive were given surveys 
to fill out at six month intervals. Interviews were used to evaluate adherence to HAART 
in the 267 patients who were on HAART. When it came to correlating the consumption 
of alcohol and adherence to HAART, the patients on HAART seemed to be less adherent 
when consuming alcohol, but when abstaining from alcohol, adherence to HAART was 
18 
 
increased. The results of the study showed that any amount of alcohol consumed was 
associated with a decrease in adherence (Samet et al., 2004). 
In a prospective cohort, 1,910 HIV-positive patients reported adherence rates to 
HAART therapy for four weeks prior to the survey. Non-adherence to HAART therapy 
was reported to be related to multiple factors such as psychiatric disorders, drug use, and 
alcohol use. In regards to alcohol consumption, patients who did drink alcohol were more 
likely to be non-adherent compared to the patients who did not drink. This study showed 
that non-adherence to HAART therapy can be multifactorial, but it still ties alcohol 
consumption in with non-adherence (Tucker et al., 2003). 
Effects of Alcohol on Disease Progression 
Of the literature chosen, it is shown that there were additional effects of alcohol 
on patients infected with HIV while taking HAART. There was a decrease in CD4+ cells 
that could lead to the progression of HIV. Baum et al. (2010) performed a prospective 
longitudinal study on a cohort of 231 HIV-infected patients. Frequent alcohol 
consumption was seen to be a factor in the decrease of CD4+ cells in patients who used 
antiretroviral therapy. In this particular study, the patients were followed for thirty 
months, and biannually blood was drawn to analyze the CD4+ cell count and viral load. 
The results of the study showed that frequent alcohol users who drank two or more drinks 
daily were about 2.91 times  more likely to present with a decline of CD4+ cell levels  to 
less than or equal to 200 cells. Also, frequent alcohol consumption was associated with a 
higher viral load, even in patients who were receiving HAART. These results show that 
the consumption of alcohol may have an effect on CD4+ cells and the viral loads leading 
to the progression of HIV in patients who are on ART (Baum et al., 2010). 
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A large observational cohort of 2,702 HIV positive patients was done to show an 
association with consuming alcohol and HIV disease progression. To show the effects of 
alcohol consumption on survival in patients with HIV, a computer simulation was used. 
The computer simulation was able to show the impact alcohol has on HAART, and on the 
survival in patients who are HIV positive. It showed that patients who consume 
hazardous amounts of alcohol were more non-adherent compared to patients who 
consumed non-hazardous amounts of alcohol. The results showed that patients who were 
non-hazardous drinkers or non-binge drinkers had a reduction in their life expectancy by 
more than a year if they drank at least once a week. Patients who drank daily had a 
decreased life expectancy by about three years. For hazardous drinkers or binge drinkers 
life expectancy was decreased by more than three years if alcohol was consumed at least 
once a week, and life expectancy was decreased by about six years if they consumed 
hazardous amounts of alcohol every day (Braithwaite et al., 2007). 
In a prospective cohort of 881 HIV-positive veterans, the correlation between the 
progression of HIV and alcohol consumption was researched at three different HIV 
clinics. In this study, patients were given surveys related to their consumption of alcohol. 
The alcohol use disorder identification test was also used. The results determined that 
twenty percent were hazardous drinkers, and thirty-three percent were binge drinkers. It 
was also found that veterans with alcohol consumption problems were associated with 
complications such as disease progression, abnormal alanine transaminase or aspartate 
transaminase levels, anemia, and multiple hepatic diseases. In this study, alcohol seemed 
to be correlated with comorbidities and disease progression of HIV, which can lead to 
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early mortality in patients who consume alcohol while taking HAART (Conigliaro et al., 
2003). 
 In a secondary analysis of a longitudinal cohort, 197 HIV positive patients were 
used to see if there was a correlation between the consumption of alcohol and the disease 
progression of HIV. In this study, patients were interviewed every six months for a total 
of seven times. Patients were asked about alcohol consumption for the past month and 
were also given breathalyzer tests before the interview started. Also, patients were to give 
a report on their adherence to HAART by reporting how many pills were taken daily 
compared to how many were prescribed. In the results, there was evidence that alcohol 
negatively affected adherence to HAART. It was shown that patients who consumed 
alcohol were not completely adherent to HAART, and had higher HIV RNA levels 
compared to those patients who did not drink. The rise in HIV RNA levels could result in 
the progression of HIV in patients who consume alcohol while taking HAART (Finucane 
et al., 2007). 
In an observational clinical cohort, 1,030 HIV-positive women were used to 
associate the consumption of alcohol with adherence to HAART therapy. The time of 
death was correlated using the Kaplan-Meier statistics and Cox proportional hazards 
regression. In this study, it was found that twenty-nine percent of patients occasionally 
drank, seventeen percent were hazardous drinkers, and thirteen percent were past 
drinkers. Also, through the Cox proportional hazards regression model, HIV-positive 
patients who were hazardous drinkers were more likely to have an earlier death compared 
to patients who abstained from alcohol (Neblett et al., 2011).  
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In another study, a cross-sectional analysis was done on 349 HIV-positive patients 
whom all had histories of drinking alcohol. Patients were interviewed and given 
questionnaires, and CD4+ cell levels and viral load levels were reviewed in the medical 
record. In the results, patients who were moderate or hazardous drinkers had high HIV 
RNA levels and lower CD4+ levels compared to those patients who did not drink. 
Overall, with lower CD4+ levels and higher HIV RNA levels, patients who were drinking 
moderate to hazardous levels of alcohol are more likely to see a progression in HIV than 
those patients who did not drink (Samet et al., 2003). 
In a prospective Cohort, 595 HIV-positive patients were checked up for a total of 
seven years to research the impact alcohol has on CD4+ cell levels and overall disease 
progression. Longitudinal regression models were used to try and find a correlation 
between the consumption of alcohol and the progression of HIV. Patients were 
interviewed and given questionnaires, and CD4+ cell levels and viral load levels were 
checked in the medical record. The results showed that thirty percent of patients were 
heavy alcohol drinkers, ten percent were moderate alcohol drinkers, and fifty-nine 
percent abstained from drinking alcohol. It was found that the consumption of alcohol 
affected those patients who were not on HAART because they had lower CD4+ cells. 
However, patients who were on HAART had CD4+ cells levels higher than those patients 
not on HAART. This study showed the possible correlation between the progression of 
HIV in patients who are not on HAART and found that CD4+ cell levels were lower in 
patients who drank alcohol when not on HAART (Samet et al., 2007). 
The consumption of alcohol likely plays a critical role when it comes to 
adherence rates to HAART, the progression of HIV, the effects on CD4+ cells and viral 
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load, and for the increase in adverse effects such as drug toxicity (Bryant et al., 2006). In 
order to improve the treatment of HIV/AIDS, patients should be thoroughly assessed for 
alcohol use, support services should be used to increase adherence rates, and other factors 
should be researched to see if the cause of non-adherence is multi-factorial. Overall, 
prevention strategies should be the most important focus for stopping the spread of HIV. 
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Chapter Five: Discussion 
 Human immunodeficiency virus has been around since about the 1800’s, its 
questioning interactions with alcohol and HAART have only been researched since 
around the late 90’s. Since then, alcohol has been seen as a significant factor in non-
adherence to HAART in patients with HIV. Also, it appears to be a factor in the effects 
on CD4+ cells and HIV RNA levels causing early mortality. Overall, it is still not a 
definitive cause of both non-adherence and early mortality in patients with HIV on 
HAART. 
Although research shows a strong correlation between the consumption of alcohol 
with HAART non-adherence and early mortality, it is still inconclusive. There were a 
variety of measurements used in the studies and it cannot be said if alcohol is the primary 
or exact factor to cause such an effect on CD4+ cells and viral load in patients with HIV 
on HAART. One thing that was seen in all the studies is that there is no definitive 
assessment in patients on HAART when it comes to the consumption of alcohol and drug 
abuse. In order to help with adherence to HAART, healthcare providers should focus on 
the assessment of alcohol use in patients by asking for a thorough history of alcohol use 
and making sure to not misinterpret this information. A distinction needs to be made in 
the responses and what the patient may mean by "a few drinks". By performing thorough 
alcohol use assessments, healthcare providers can help adherence rates and can 
potentially prevent the progression of HIV in patients on HAART. 
  Another result shown in the studies was that non-adherence to HAART was 
caused by more than just alcohol use. Many factors contributed to non-adherence rates 
such as stress, forgetting to take HAART, having children, having partners, and even 
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feeling that taking HAART would not delay the progression of HIV. All of these factors 
should be further researched to find why there is such a strong correlation with non-
adherence to HAART. Also, the exact causes for the effects of alcohol on CD4+ cells are 
still undetermined and should be further researched to pinpoint a more exact reason for a 
decrease in CD4+ cells when drinking alcohol on HAART. 
  Although research is only beginning to surface about the interactions between the 
consumption of alcohol and non-adherence to HAART, there are still many gaps in the 
research. Many factors need to be researched to find the exact mechanism in which non-
adherence, disease progression, and early mortality occurs. Early and thorough 
assessment of alcohol use should be a priority in patients on HAART. Patients should be 
taught about the possible effects alcohol has on HAART, and referral to support groups 
should be used to help patients increase adherence rates. Also, patients should book 
follow-up appointments with healthcare providers to prevent complications. Lastly, 
preventative strategies should be formed to decrease the spread of HIV/AIDS in the 
United States.  
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Appendix A 
Summary of Articles Reviewed; Ordered by Alphabetical Order  
 
Source 
 
 
Purpose 
 
Population 
 
Study 
 
Results 
Baum et al., 
2010 
To see if the 
consumption of 
alcohol cause 
the progression 
of HIV through 
non-adherence. 
231 HIV + 
patients 
Prospective 
Longitudinal 
Study 
Frequent alcohol 
drinkers are more 
likely to be non-
adherent to HAART, 
which could lead to 
disease progression in 
patients with HIV. 
Braithwaite 
et al., 2005 
To determine if 
there is a 
relationship 
between the 
consumption of 
alcohol and non-
adherence. 
2,702 HIV 
+ Veterans 
in Care 
 
 
 
 
Observational 
Study, 
Veterans Aging 
Cohort Study 
There is a relationship 
between alcohol 
consumption and 
non-adherence as 
binge drinkers were 
non-adherent 11% on 
days of drinking 
versus abstainers who 
were non-adherent 
only 2.4% of time 
during reported days. 
Braithwaite 
et al., 2007 
To see if alcohol 
affects survival 
of patients with 
HIV through 
non-adherence 
of HAART 
therapy 
2,702 HIV 
+ patients 
Large 
Observational 
Cohort 
Hazardous alcohol 
consumption had a 
major effect of 
survival by 
decreasing overall 
survival by three 
years and those who 
are non-hazardous 
drinkers, survival was 
decreased by about 
one year. 
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Source 
 
 
Purpose 
 
Population 
 
Study 
 
Results 
Braithwaite 
et al., 2008 
To see if the 
consumption of 
alcohol is 
correlated with 
non-adherence to 
HAART therapy 
in patients with 
HIV. 
1,529 HIV 
+ Patients 
Cross 
Sectional 
Analysis 
Non-adherence to 
HAART therapy 
was significantly 
associated with the 
consumption of 
alcohol. 
Chander et 
al., 2006 
 
 
 
 
 
 
 
 
 
To see the effects 
of the 
consumption of 
alcohol on 
adherence. 
1,711 HIV+ 
Patients 
Observational 
Clinical 
Cohort 
Hazardous drinking 
was associated with 
non-adherence to 
HAART therapy 
compared to 
abstainers. 
 
 
 
 
 
 
Chesney et 
al., 2000 
 
 
 
 
 
 
To measure 
adherence to 
HAART therapy, 
and to find 
underlying reasons 
why non-
adherence occurs 
in patients with 
HIV. 
75 HIV + 
Patients 
Cross-
Sectional 
Survey 
Patients who were 
non-adherent were 
most likely 
consuming alcohol, 
working away from 
home, or enrolling 
in clinical trials to 
gain access to 
medications. 
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Source 
 
 
Purpose 
 
Population 
 
Study 
 
Results 
Conigliaro 
et al., 2003 
To find and 
describe the 
correlation of 
alcohol 
consumption and 
the progression of 
HIV. 
881 HIV+ 
Veterans 
Prospective 
Cohort 
Veterans who were 
binge or hazardous 
drinkers were 
associated with 
disease progression 
in HIV. 
Cook et 
al., 2001 
 
To find a 
correlation 
between the 
consumption of 
alcohol and non-
adherence to 
HAART therapy. 
212 HIV+ 
Patients 
Cross Sectional 
Survey 
Medication non-
adherence was 
related to and seen 
more in patients 
who reported 
hazardous or binge 
drinking. 
Finucane 
et al., 2007 
To follow up on 
patients to see if 
there was an 
association of 
consuming alcohol 
and disease 
progression in 
patients with HIV. 
197 HIV + 
Patients 
Secondary 
analysis of a 
longitudinal 
cohort. 
Patients who are 
infected with HIV 
and consume 
alcohol are not fully 
adherent to HAART 
therapy and have 
higher viral load 
levels which lead to 
the progression of 
HIV. 
Golin et 
al., 2002 
 
 
 
 
 
 
 
 
To see if there was 
an association 
between alcohol 
consumption and 
medication non-
adherence. 
 
117 HIV + 
Patients 
 
 
 
 
Prospective 
Observational 
Cohort 
Patients who drank 
alcohol were 
adherent to 66% of 
the doses compared 
to being adherent 
74% with non-
drinkers. 
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Source 
 
 
Purpose 
 
Population 
 
Study 
 
Results 
Hendershot 
et al., 2009 
To evaluate the 
findings across 
studies of the 
association of 
alcohol and non-
adherence in 
patients with 
HIV. 
Over 20,000 
HIV + 
Participants 
Meta-
Analysis 
There is a significant 
association between 
both the consumption 
of alcohol and non-
adherence in patients 
with HIV, which 
could lead to overall 
disease progression in 
patients. 
Hicks et al., 
2007 
To the effects of 
hazardous or 
binge drinking 
on adherence to 
HAART. 
659 HIV+ 
Patients 
Cross- 
Sectional 
Hazardous or binge 
drinkers were less 
likely to be adherent 
than former drinkers 
or never drinkers. 
Lehavot et 
al., 2001 
To examine the 
impact of 
alcohol on 
HAART non-
adherence 
224 HIV + 
Patients 
Longitudinal 
Random 
Control Trial 
Consuming alcohol is 
negatively associated 
with adherence to 
HAART in patients 
with HIV. 
 
 
Lucas et al., 
2002 
To assess the 
association with 
drinking alcohol 
and non-
adherence. 
695 HIV+ 
Patients 
Prospective 
Cohort 
Those who drank 
alcohol were 
correlated with non-
adherence to HAART 
therapy, where as 
those who quit 
drinking were 
correlated with 
adherence 
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Source 
 
 
Purpose 
 
Population 
 
Study 
 
Results 
Murphy 
et al., 
2002 
To find what 
causes non-
adherence to 
HAART therapy 
with women with 
children. 
52 HIV + 
Women with 
Children 
Cross sectional 
data used from a 
Prospective 
Observational 
Cohort 
Adherence rates 
were found to be 
43%-56% due to 
multiple factors 
such as consuming 
alcohol, stress, 
partners, and 
children. 
Neblett 
et al., 
2011 
To see if the 
consumption of 
alcohol was related 
to earlier death in 
women on 
combination 
antiretroviral 
therapy. 
1,030 HIV + 
women 
Observational 
Cohort 
Hazardous alcohol 
consumption was 
associated with 
earlier death in 
women diagnosed 
with HIV on 
antiretroviral 
therapy. 
Samet et 
al., 2003 
To see if there is a 
relationship 
between the 
consumption of 
alcohol and the 
progression of 
HIV. 
349 HIV+ 
Patients 
Cross-Sectional 
Analysis 
Patients who drink 
alcohol have low 
CD4+ levels which 
may have a 
significant impact 
on the progression 
of HIV. 
Samet et 
al., 2004 
To find an 
association 
between the 
consumption of 
alcohol and 
adherence HAART 
therapy. 
349 HIV+ 
Patients 
Prospective 
Cohort 
Any amount of 
alcohol use is 
related to non-
adherence to 
HAART Therapy in 
patients with HIV. 
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Source 
 
 
Purpose 
 
Population 
 
Study 
 
Results 
Samet et 
al., 2007 
To assess the 
correlation between 
alcohol consumption 
and the progression 
of HIV. 
595 HIV+ 
Patients 
Two 
Prospective 
Cohorts 
Consuming alcohol 
has a negative impact 
on patients not on 
HAART because it 
lowers CD4+ levels. 
Tucker 
et al., 
2003 
To investigate the 
association of 
HAART non-
adherence with the 
consumption of 
alcohol. 
1,910 HIV + 
Patients on 
HAART 
Prospective 
Cohort 
Moderate to heavy 
drinkers were more 
likely to be non-
adherent than those 
who did not drink 
alcohol. 
 
